Although a greater risk of CNS relapse may emerge with immunotherapy-based backbones, toxicities associated with chemotherapy are avoided.
Hannah Goulart, MD
Advertisement
Articles by Hannah Goulart, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Giredestrant Displays IDFS Improvement vs SOC ET in ER+/HER2– BC
2
Anito-Cel May Have Efficient Mechanism in R/R Multiple Myeloma Treatment
3
Axi-cel Produces Enduring Real-World Responses in R/R Follicular Lymphoma
4
How Do Experts Think Dato-DXd Should Be Used in NSCLC?
5
